Telomere und Telomerase – ihre Bedeutung als prognostischer ...

LITERATURVERZEICHNIS 147
6. Literaturverzeichnis
Aogi, K., Woodman, A., Urquidi, V., Mangham, D. C., Tarin, D., and Goodison, S. (2000). Telomerase
activity in soft-tissue and bone sarcomas. Clin Cancer Res 6, 4776-4781.
Bachor, C., Bachor, O. A., and Boukamp, P. (1999). Telomerase is active in normal gastrointestinal
mucosa and not up-regulated in precancerous lesions. J Cancer Res Clin Oncol 125, 453-460.
Barma, D. K., Elayadi, A., Falck, J. R., and Corey, D. R. (2003). Inhibition of telomerase by BIBR 1532
and related analogues. Bioorg Med Chem Lett 13, 1333-1336.
Beattie, T. L., Zhou, W., Robinson, M. O., and Harrington, L. (1998). Reconstitution of human
telomerase activity in vitro. Curr Biol 8, 177-180.
Bieche, I., Nogues, C., Paradis, V., Olivi, M., Bedossa, P., Lidereau, R., and Vidaud, M. (2000).
Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse
transcription-polymerase chain reaction assay. Clin Cancer Res 6, 452-459.
Biroccio, A., Gabellini, C., Amodei, S., Benassi, B., Del Bufalo, D., Elli, R., Antonelli, A., D'Incalci, M.,
and Zupi, G. (2003). Telomere dysfunction increases cisplatin and ecteinascidin-743 sensitivity of
melanoma cells. Mol Pharmacol 63, 632-638.
Blackburn, E. H. (1991). Structure and function of telomeres. Nature 350, 569-573.
Blackburn, E. H., and Gall, J. G. (1978). A tandemly repeated sequence at the termini of the
extrachromosomal ribosomal RNA genes in Tetrahymena. J Mol Biol 120, 33-53.
Blasco, M. A. (2002). Telomerase beyond telomeres. Nat Rev Cancer 2, 627-633.
Boldrini, L., Faviana, P., Gisfredi, S., Zucconi, Y., Di Quirico, D., Donati, V., Berti, P., Spisni, R.,
Galleri, D., Materazzi, G., et al. (2002). Evaluation of telomerase in the development and progression
of colon cancer. Int J Mol Med 10, 589-592.
Bovee, J. V., van Den Broek, L. J., Cleton-Jansen, A. M., and Hogendoorn, P. C. (2001).
Chondrosarcoma is not characterized by detectable telomerase activity. J Pathol 193, 354-360.
Brentnall, T. A. (1999). Risk factors for development of colorectal cancer in inflammatory bowel
disease. In Advances in inflammatory bowel diseases., P. Rutgeerts, J. F. Colombel, S. B. Hanauer, J.
Schölmerich, G. N. J. Tytgat, and A. van Gossum, eds. (Dordrecht/ Boston/ London, Kluwer Academic
Publishers), pp. 159-167.
Broccoli, D., Young, J. W., and de Lange, T. (1995). Telomerase activity in normal and malignant
hematopoietic cells. Proc Natl Acad Sci U S A 92, 9082-9086.
Bryan, T. M., and Reddel, R. R. (1997). Telomere dynamics and telomerase activity in in vitro
immortalised human cells. Eur J Cancer 33, 767-773.
Burger, A. M., Double, J. A., and Newell, D. R. (1997). Inhibition of telomerase activity by cisplatin in
human testicular cancer cells. Eur J Cancer 33, 638-644.
Chiu, C. P., and Harley, C. B. (1997). Replicative senescence and cell immortality: the role of
telomeres and telomerase. Proc Soc Exp Biol Med 214, 99-106.
Colgin, L. M., Wilkinson, C., Englezou, A., Kilian, A., Robinson, M. O., and Reddel, R. R. (2000). The
hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia 2, 426-
432.
Cong, Y. S., Wen, J., and Bacchetti, S. (1999). The human telomerase catalytic subunit hTERT:
organization of the gene and characterization of the promoter. Hum Mol Genet 8, 137-142.